These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells. Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946 [TBL] [Abstract][Full Text] [Related]
4. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor. Litvinov IV; Antony L; Dalrymple SL; Becker R; Cheng L; Isaacs JT Prostate; 2006 Sep; 66(12):1329-38. PubMed ID: 16835890 [TBL] [Abstract][Full Text] [Related]
5. Differential posttranscriptional regulation of androgen receptor gene expression by androgen in prostate and breast cancer cells. Yeap BB; Krueger RG; Leedman PJ Endocrinology; 1999 Jul; 140(7):3282-91. PubMed ID: 10385425 [TBL] [Abstract][Full Text] [Related]
6. Honokiol, a chemopreventive agent against skin cancer, induces cell cycle arrest and apoptosis in human epidermoid A431 cells. Chilampalli C; Guillermo R; Kaushik RS; Young A; Chandrasekher G; Fahmy H; Dwivedi C Exp Biol Med (Maywood); 2011 Nov; 236(11):1351-9. PubMed ID: 21908486 [TBL] [Abstract][Full Text] [Related]
7. Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins. Xu Y; Chen SY; Ross KN; Balk SP Cancer Res; 2006 Aug; 66(15):7783-92. PubMed ID: 16885382 [TBL] [Abstract][Full Text] [Related]
8. Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells. Hååg P; Bektic J; Bartsch G; Klocker H; Eder IE J Steroid Biochem Mol Biol; 2005 Aug; 96(3-4):251-8. PubMed ID: 15982869 [TBL] [Abstract][Full Text] [Related]
9. Growth inhibition of androgen-responsive prostate cancer cells with brefeldin A targeting cell cycle and androgen receptor. Rajamahanty S; Alonzo C; Aynehchi S; Choudhury M; Konno S J Biomed Sci; 2010 Jan; 17(1):5. PubMed ID: 20102617 [TBL] [Abstract][Full Text] [Related]
10. Galbanic acid decreases androgen receptor abundance and signaling and induces G1 arrest in prostate cancer cells. Zhang Y; Kim KH; Zhang W; Guo Y; Kim SH; Lü J Int J Cancer; 2012 Jan; 130(1):200-12. PubMed ID: 21328348 [TBL] [Abstract][Full Text] [Related]
11. Vitex rotundifolia Fruit Suppresses the Proliferation of Human Colorectal Cancer Cells through Down-regulation of Cyclin D1 and CDK4 via Proteasomal-Dependent Degradation and Transcriptional Inhibition. Song HM; Park GH; Park SB; Kim HS; Son HJ; Um Y; Jeong JB Am J Chin Med; 2018; 46(1):191-207. PubMed ID: 29298515 [TBL] [Abstract][Full Text] [Related]
12. Amniotic membrane-derived cells inhibit proliferation of cancer cell lines by inducing cell cycle arrest. Magatti M; De Munari S; Vertua E; Parolini O J Cell Mol Med; 2012 Sep; 16(9):2208-18. PubMed ID: 22260183 [TBL] [Abstract][Full Text] [Related]
13. SGK3 is an androgen-inducible kinase promoting prostate cancer cell proliferation through activation of p70 S6 kinase and up-regulation of cyclin D1. Wang Y; Zhou D; Chen S Mol Endocrinol; 2014 Jun; 28(6):935-48. PubMed ID: 24739041 [TBL] [Abstract][Full Text] [Related]
14. Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation. Burd CJ; Petre CE; Morey LM; Wang Y; Revelo MP; Haiman CA; Lu S; Fenoglio-Preiser CM; Li J; Knudsen ES; Wong J; Knudsen KE Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2190-5. PubMed ID: 16461912 [TBL] [Abstract][Full Text] [Related]
15. A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells. Recchia AG; Musti AM; Lanzino M; Panno ML; Turano E; Zumpano R; Belfiore A; Andò S; Maggiolini M Int J Biochem Cell Biol; 2009 Mar; 41(3):603-14. PubMed ID: 18692155 [TBL] [Abstract][Full Text] [Related]
16. Regulation of a novel androgen receptor target gene, the cyclin B1 gene, through androgen-dependent E2F family member switching. Li Y; Zhang DY; Ren Q; Ye F; Zhao X; Daniels G; Wu X; Dynlacht B; Lee P Mol Cell Biol; 2012 Jul; 32(13):2454-66. PubMed ID: 22508987 [TBL] [Abstract][Full Text] [Related]
17. Direct modulation of rheumatoid inflammatory mediator expression in retinoblastoma protein-dependent and -independent pathways by cyclin-dependent kinase 4/6. Nonomura Y; Nagasaka K; Hagiyama H; Sekine C; Nanki T; Tamamori-Adachi M; Miyasaka N; Kohsaka H Arthritis Rheum; 2006 Jul; 54(7):2074-83. PubMed ID: 16802342 [TBL] [Abstract][Full Text] [Related]
18. DHT selectively reverses Smad3-mediated/TGF-beta-induced responses through transcriptional down-regulation of Smad3 in prostate epithelial cells. Song K; Wang H; Krebs TL; Wang B; Kelley TJ; Danielpour D Mol Endocrinol; 2010 Oct; 24(10):2019-29. PubMed ID: 20739403 [TBL] [Abstract][Full Text] [Related]
19. Protein kinase C delta inhibits Caco-2 cell proliferation by selective changes in cell cycle and cell death regulators. Cerda SR; Mustafi R; Little H; Cohen G; Khare S; Moore C; Majumder P; Bissonnette M Oncogene; 2006 May; 25(22):3123-38. PubMed ID: 16434969 [TBL] [Abstract][Full Text] [Related]
20. Androgen induces differentiation of a human papillomavirus 16 E6/E7 immortalized prostate epithelial cell line. Ling MT; Chan KW; Choo CK J Endocrinol; 2001 Jul; 170(1):287-96. PubMed ID: 11431162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]